The QualityStocks Daily Stock List
- AgraFlora Organics International, Inc. (AGFAF)
- Argonaut Gold, Inc. (ARNGF)
- BioCardia, Inc. (BCDA)
- Fernhill Corporation (FERN)
- Sabina Gold & Silver Corp. (SGSVF)
- Track Group, Inc. (TRCK)
- Zyla Life Sciences (ZCOR)
- Blue Eagle Lithium, Inc. (BEAG)
- Natural Health Farm Holdings, Inc. (NHEL)
- Pura Naturals, Inc. (PNAT)
- CareView Communications, Inc. (CRVW)
- Lexington Biosciences, Inc. (LXGTF)
- Ocean Thermal Energy Corporation (CPWR)
- American Power Group Corp. (APGI)
AgraFlora Organics International, Inc. (AGFAF)
Marijuana Stocks, TipRanks, Pot Stock News, TradingView, Investing.com, Stockhouse, The Street, Pot Stocks, IRW Newsletter, Investors Hub, The WS News Publisher, Nasdaq, Dividend Investor, GlobeNewswire, and Stockwatch reported previously on AgraFlora Organics International, Inc. (AGFAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
AgraFlora Organics International, Inc. is a growth oriented and diversified international cannabis company listed on the OTC Markets. It owns an indoor cultivation operation (ACMPR licensed- 8,800 sq. ft.) in London, Ontario. In addition, the Company is a joint venture (JV) partner (a 70 percent interest) in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, British Columbia. AgraFlora Organics International has its corporate headquarters in Vancouver, British Columbia.
The Company has a world-class team with broad experience with natural farming techniques, biodynamics, genetics and strains. The foundation of AgraFlora’s products is on a very large library of proprietary genetics in clone and seed form that have been bred in first-rate conditions.
AgraFlora Organics is a vertically integrated cannabis enterprise equipped with a strong portfolio of licensed upstream, downstream and product formulation assets. Furthermore, it operates a flagship 51,500 sq. ft. edibles manufacturing facility in Winnipeg, Manitoba. The Company’s brands include Canutra Naturals Ltd., Edibles and Infusions, HowlBrands, Whole Hemp Health, Eurasia Infused, True Focus, Potluck, and Health Cap Holdings.
AgraFlora Organics International announced this past September that its wholly-owned subsidiary Canutra Naturals was awarded a cannabis research licence by Health Canada under the Cannabis Regulations Act. The Research License permits Canutra Natural to pursue the development of proprietary cannabis genetics and phenotypes at its flagship 76-acre campus in Kent County, New Brunswick.
Earlier this month, AgraFlora Organics International announced the introduction of four innovative cannabinoid infused Stock Keeping Units (SKUs) for production at its 51,500 square foot GMP Winnipeg Edibles Facility. The Company’s intention is to produce pectin and/or gelatine based CBD (cannabidiol) or THC (Tetrahydrocannabinol) infused gummy SKUs branded with Mesoamerican attributes.
It will produce the following: Rojo - a strawberry flavoured pectin based cannabinoid-infused gummy SKU; Naranja - a tangerine flavoured gelatine based cannabinoid-infused gummy SKU; Azul - a blue raspberry flavoured gelatine based cannabinoid-infused gummy SKU; and Verde - a green apple flavoured pectin based cannabinoid-infused gummy SKU.
Last week, AgraFlora Organics International announced it received a purchase order from Gateway Newstands for its Whole Hemp Health (WHH) organic lip balm SKU. Gateway’s purchase order and subsequent listing of a secondary AgraFlora SKU secures added high-visibility Canadian shelf space for AgraFlora’s growing line of organic cannabis sativa seed oil infused consumer packaged goods (CPGs). AgraFlora was awarded approved supplier status by Gateway on October 9, 2019. The Company now has two unique SKUs on the shelves of Gateway’s 200 high-traffic storefronts.
AgraFlora Organics International, Inc. (AGFAF), closed Wednesday's trading session at $0.1397, up 8.2946%, on 311,098 volume with 92 trades. The average volume for the last 3 months is 573,768 and the stock's 52-week low/high is $0.090000003/$0.639699995.
Argonaut Gold, Inc. (ARNGF)
StocksBeat, Whale Wisdom, The Northern Miner, Stock Guru, TipRanks, Mining Stock Valuator, OTC Markets, MarketBeat, StockScores, Canadian Mining Journal, Invest Tribune, Wallmine, StockInvest, and Dividend Investor reported earlier on Argonaut Gold, Inc. (ARNGF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Argonaut Gold, Inc. engages in exploration, mine development, and production activities in North America. The Company primarily explores for gold and silver deposits. Its principal assets include the El Castillo mine located in the State of Durango, Mexico; and the San Agustin project located in the State of Durango, Mexico. In 2019, Argonaut Gold’s plan was to invest $50 to $60 million in capital expenditures. Argonaut Gold is headquartered in Reno, Nevada. The Company lists on the OTC Markets.
Together, the El Castillo mine and the San Agustin project form the El Castillo Complex in Durango, Mexico, and the La Colorada mine in Sonora, Mexico. Furthermore, Argonaut Gold’s advanced exploration projects include the San Antonio project in Baja California Sur, Mexico; the Cerro del Gallo project in Guanajuato, Mexico; and the Magino project in the Province of Ontario, Canada. Additionally, the Company has several exploration stage projects, all of which are located in North America.
This year, Argonaut Gold expects to produce more than 200,000 GEOs (gold equivalent ounces) annually from its existing operations. This would reflect greater than 65 percent production growth from 2017 through 2019. This production growth is mainly driven by the ramp up of the El Castillo Complex with the addition of San Agustin and the extension of mine life at El Castillo subsequent to the San Juan concession purchase from Fresnillo Plc, as well as higher anticipated grades at La Colorada as mining transitions to the El Creston pit.
In late October, Argonaut Gold announced that the earlier announced illegal blockade at the El Castillo mine was lifted and operations at the mine have resumed. The Company reached a tentative agreement with the Atotonilco ejido that was scheduled to be voted on by the Atotonilco ejido on November 11 , 2019. As part of this agreement, the Atotonilco ejido agreed to lift the blockade pending ratification.
Argonaut Gold, Inc. (ARNGF), closed Wednesday's trading session at $1.3895, up 3.694%, on 60,384 volume with 53 trades. The average volume for the last 3 months is 40,492 and the stock's 52-week low/high is $0.852100014/$2.15000009.
BioCardia, Inc. (BCDA)
Zacks, Market Chameleon, Stock Twits, TMXmoney, Insider Tracking, Street Insider, Stockopedia, Stockhouse, Market Screener, MarketBeat, Capital Cube, Wallet Investor, AI Stock Finder, Dividend Investor, Stockwatch and TipRanks reported beforehand on BioCardia, Inc. (BCDA), and today we report on the Company, here at the QualityStocks Daily Newsletter.
BioCardia, Inc. is a leader in the development of comprehensive solutions for cardiovascular regenerative therapies. Its biotherapeutic product candidates in clinical development are CardiAMP and CardiALLO cell therapies. In addition, the Company offers the Helix biotherapeutic delivery system; and the Morph vascular access product line, which provides catheter products. A clinical-stage regenerative medicine enterprise, BioCardia is headquartered in San Carlos, California and lists on the NasdaqCM.
Additionally, BioCardia partners with other biotherapeutic companies. This is to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia, as well as acute myocardial infarction.
BioCardia’s lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System. It provides an autologous bone marrow derived cell therapy (utilizing a patient's own cells) for the treatment of two clinical indications. These are heart failure that develops after a heart attack and chronic myocardial ischemia.
The Company’s second therapeutic candidate is the investigational CardiALLO™ Cell Therapy System. This is an allogeneic culture expanded "off the shelf" cell therapy derived from donor bone marrow cells that have been identified to meet particular criteria. The therapy has the potential to be advanced for numerous clinical indications, including heart failure.
This past May, BioCardia announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing different cardiovascular catheters into the heart. This includes through the left side of the heart via the interatrial septum.
The AVANCE steerable introducer family takes advantage of Morph “DNA” technology. This is an enhancement of BioCardia’s FDA-cleared Morph steerable introducer that adds several features that make the devices ideal for use in transseptal procedures and are designed to improve upon commercially-available offerings.
Last month, BioCardia announced renewal of the CE Mark for the Helix™ Biotherapeutic Delivery Catheter and Morph® Universal Deflectable Guide Catheter, both used in the delivery of biotherapeutics to the heart. CE Mark renewal enables BioCardia to continue supporting partners conducting biotherapeutic clinical trials outside of the United States, including CellProThera and Centro Cardiologico Monzino, and also commercial sales in the European Union (EU) and other countries that recognize the CE Mark through May 2024.
In Q3 2019, BioCardia initiated the commercial release of its AVANCE Bi-Directional Steerable Introducer Sheath for introducing different cardiovascular catheters into the heart, including transseptal procedures. The device addresses shortcomings associated with presently available introducers through providing uniform bending in all directions intended to reduce “whip,” including a smooth tip-to dilator transition to promote ease of entry into the left atrium, and increasing steerability to improve access to hard-to-reach sites.
Moreover, in Q3 2019, BioCardia signed an extension to its existing agreement with AstraZeneca for its Helix™ biotherapeutic delivery system catheter, shown to present the lowest risk to patients for cell and gene delivery to the heart (that included a $1 million upfront payment). The agreement is exclusive with respect to a class of biotherapeutic agents that BioCardia is not presently developing on its own or with any other party.
BioCardia, Inc. (BCDA), closed Wednesday's trading session at $3.75, off by 2.5974%, on 12,626 volume with 63 trades. The average volume for the last 3 months is 28,506 and the stock's 52-week low/high is $3.51999998/$4.42999982.
Fernhill Corporation (FERN)
TipRanks, Insider Financial, Morningstar, PR Newswire, Financial Buzz, 4-Traders, Dividend.com, Stockwatch, Wallet Investor, Stockhouse, Oilandgas360.com, Nasdaq, Seeking Alpha, MarketWatch, GlobeNewswire, and InvestorsHub reported earlier on Fernhill Corporation (FERN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Fernhill Corporation is a Media, Technology and Entertainment Company listed on the OTC Markets. Its emphasis is on building and incubating Mobile and Web applications that mainly use the Company’s customizable Matching Platform. The Company states that these applications will ultimately come from a broad array of genres. These include, but are not limited to, Live Advice, Cannabis, Real Estate, Crypto-currency, Sports, and Entertainment.
The Company has recently expanded into Entertainment and Technology. Fernhill comprises a group of diverse artists and collaborators with a broad variety of talents and connections. This include writers, directors, developers, managers, as well as social media influencers.
Mr. Marc Lasky is the Chief Executive Officer and Director of Fernhill. Mr. Lasky’s career includes almost 30 years as a production and marketing executive. He has a Bachelor of Science in Business Administration, with concentrations in Marketing and Finance from Tulane University’s A.B. Freeman School of Business.
This past September, Fernhill announced the acquisition of the MetaMedia web application, which serves as a powerful social media marketing engine for businesses everywhere. With its unique ad-free solution for the most popular social media networks, MetaMedia provides an alternative to traditional marketing campaigns. MetaMedia creates completely integrated marketing campaigns that guide leads and customers through a seamless journey for any brand using strong marketing automation algorithms to build and route their audience based on their behaviors and preferences.
Today, Fernhill announced the acquisition of Numuni, Inc. This is an ad-free marketing platform founded on cryptocurrency mining, to disrupt conventional advertising models. Numuni disrupts the present display advertising model through enabling the latent computing power of the masses in a privacy-friendly way that benefits publishers, advertisers, as well as consumers alike.
Mr. Robert Reynolds, Chief Executive Officer of Numuni, said, “We change the direction of money slightly, but significantly, to make display advertising better. We did it before, and we’re about to do it again. Just evolved and more effective in all the right ways.”
Fernhill Corporation (FERN), closed Wednesday's trading session at $0.0004, off by 20.00%, on 82,355,696 volume with 63 trades. The average volume for the last 3 months is 13,636,413 and the stock's 52-week low/high is $0.000399999/$0.001399999.
Sabina Gold & Silver Corp. (SGSVF)
Market Seat, The Online Investor, Streetwise Reports, Web News Observer, The Prospector News, Northern Miner, GlobeNewswire, MingNewsFeed.com, 24Hgold, TradingView, Stockhouse, Market Screener, Resource World, Wallet Investor, Dividend Investor, Junior Mining Network and TMXmoney reported beforehand on Sabina Gold & Silver Corp. (SGSVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sabina Gold & Silver Corp. is an emerging precious metals company headquartered in Vancouver, British Columbia. It has district scale, advanced, high grade gold assets in one of the world’s newest, politically stable mining jurisdictions - Nunavut, Canada. The Company has its 100 percent owned Back River Gold Project. Furthermore, the Company owns a significant silver royalty on Glencore’s Hackett River Project. Sabina Gold & Silver lists on the OTC Markets Group’s OTCQX.
Sabina released a Feasibility Study (FS) on its Back River Gold Project. The FS presents a project designed on a fit-for purpose basis, with the potential to produce about 200,000 ounces a year for roughly 11 years with a fast payback of 2.9 years.
The Project received its final Project Certificate on December 19, 2017. On November 14, 2018, it received its Type A Water License. The Project is now in receipt of all major authorizations for construction and operations. In addition, the silver royalty on Hackett River’s silver production comprises 22.5 percent of the first 190 million ounces produced and 12.5 percent of all silver produced subsequently.
Last week, Sabina Gold & Silver reported interim financial results for the quarter ended September 30, 2019. For the three and nine months ended September 30, 2019, Sabina reported Net Losses of $0.6 million or $0.00 per share and $6.7 million or $0.02 per share respectively. The year-to-date Net Loss includes an after-tax write-down of $4.2 million on non-core Red Lake mineral properties. Excluding the effect of the mineral property write-down, the Adjusted Net Losses for the three and nine months ended September 30, 2019 would be $0.6 million or $0.00 per share and $2.5 million or $0.01 per share respectively.
In addition, last week, Sabina Gold & Silver released its inaugural 2018/19 ESG report. The document highlights the Company’s commitment to environmental, social and governance priorities for its permitted Back River Gold Project. Since signing the Inuit Impact Benefit Agreement with The Kitikmeot Inuit Association in mid-2018 Sabina Gold & Silver has continued to develop strategies to positively effect its Northern partners.
The ESG Report outlines the Company’s commitment to governance and integrity, value for stakeholders, value for employees, value for society and environmental sustainability, and also climate change. Moreover, the ESG Report outlines Sabina Gold & Silver’s commitment to the economy, society and environment in Nunavut.
Sabina Gold & Silver Corp. (SGSVF), closed Wednesday's trading session at $1.22, up 1.8194%, on 51,076 volume with 57 trades. The average volume for the last 3 months is 296,924 and the stock's 52-week low/high is $0.730000019/$1.72459995.
Track Group, Inc. (TRCK)
Glassdoor, Pitch Book, Simply Wall St, MarketWatch, Stockhouse, TMXmoney, Morningstar, Market Screener, Wallet Investor, and PR Newswire reported earlier on Track Group, Inc. (TRCK), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Track Group, Inc. is an international leader in providing end-to-end location monitoring and predictive behavioral solutions. These combine real-time tracking devices and professional monitoring services with advanced data analytics. In essence, the Company provides community corrections agencies with offender tracking and monitoring services. Track Group has its corporate office in Naperville, Illinois. The Company’s shares trade on the OTC Markets Group’s OTCQX.
At present, Track Group’s emphasis is delivering electronic monitoring products and services for the worldwide criminal justice market. Its growth strategy is to continue expanding its hardware-agnostic data analytics platform and software applications. This is to enable professionals in security, law enforcement, corrections, and rehabilitation organizations globally with single-sourced offender management solutions, which integrate reliable intervention technologies to support re-socialization and monitoring initiatives. The Company’s core business is location tracking and analytics.
Track Group has a completely integrated portfolio of solutions designed to increase public safety by improving the management of offenders. This is while enhancing rehabilitation outcomes. The Company has more than 12 years of offender monitoring experience. The total number of offenders monitored worldwide as of January 2019 was 35,000+.
Regarding Location Analytics, Track Group Analytics is a suite of software applications used to analyze GPS tracking data. It performs the data analysis in minutes. Moreover, it provides a user-friendly interface to interact with the results. Currently, this software is in use by State and Local Police, Federal Police, Intelligence Organizations, and Militaries in the Western world. In addition to a wide user base, Track Group Analytics is also in the current Surveillance Training curriculum at the US DHS Federal Law Enforcement Training Center (FLETC).
This past August, Track Group announced it successfully deployed Empower, the world's first integrated victim notification app, to Sheriffs, Probation and Correctional agencies worldwide. Empower creates a "mobile" geo-zone around a victim's own smartphone, which works in tandem with the associated offenders GPS tracking bracelet to provide early warning notification if offenders ever violate their restraining orders.
In the event an offender wearing a GPS bracelet comes within a court ordered distance of their victim, assigned with the Empower app, an amber alert style alarm is generated followed rapidly by contact from law enforcement guiding the victim to a safe location. Simultaneously, law enforcement dispatches units to the victim and offender locations in real time to intervene.
Track Group, Inc. (TRCK), closed Wednesday's trading session at $0.37, even for the day, on 130 volume. The average volume for the last 3 months is 559 and the stock's 52-week low/high is $0.370000004/$0.800000011.
Zyla Life Sciences (ZCOR)
Street Insider, BioPortfolio, OTC Markets, Biospace, VentureLine, Market Screener, Last10k, Stockwatch, Stockopedia, PR Newswire, InvestorsHub, Seeking Alpha, MarketWatch, Dividend Investor, Nasdaq, and Simply Wall St reported previously on Zyla Life Sciences (ZCOR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Zyla Life Sciences is a commercial-stage life sciences company listed on the OTC Markets OTCQX. The Company’s dedication is to bringing important products to patients and healthcare providers. Its focus is on marketing its portfolio of medicines for pain and inflammation. The Company was previously known as Egalet Corporation. Established in 2010, Zyla Life Sciences is headquartered in Wayne, Pennsylvania.
Zyla’s portfolio includes six products. These comprise SPRIX® (ketorolac tromethamine) Nasal Spray; ZORVOLEX® (diclofenac); VIVLODEX® (meloxicam); INDOCIN® (indomethacin) suppositories; INDOCIN® oral suspension; and OXAYDO® (oxycodone HCI, USP) tablets for oral use only —CII.
To add to its product portfolio, Zyla Life Sciences is looking to acquire more product candidates or approved products to develop and commercialize in areas consistent with its present emphasis or complementary therapeutic areas. The Company’s objective is to become a completely integrated life sciences company that develops, manufactures and markets products that make a difference in patients’ lives.
Last week, Zyla Life Sciences reported financial results for Q3 ended September 30, 2019, including Net Sales from commercial products. Net Product Sales were $22.4 million for the three months ended September 30, 2019 versus $8.2 million for the three months ended September 30, 2018. The increase was primarily because of the addition of the five acquired products at the end of January 2019.
Zyla had positive Net Cash Flow of $6.5 million for the quarter ended September 30, 2019. The Company’s Net Loss for the three months ended September 30, 2019 was $10.3 million versus a Net Loss of $51.2 million for the three months ended September 30, 2018.
Mr. Todd Smith, President and Chief Executive Officer of Zyla Life Sciences, said, "With our expanded product portfolio, we had third quarter net product sales of $22.4 million, almost three times net product sales for the same period in 2018. In the third quarter, we generated $6.5 million in net cash due to our product portfolio expansion, while maintaining similar operating expenses and commercial infrastructure. We continue to identify areas to increase efficiencies and improve our commercial impact."
Zyla Life Sciences (ZCOR), closed Wednesday's trading session at $2.35, up 9.3023%, on 26,500 volume with 12 trades. The average volume for the last 3 months is 1,441 and the stock's 52-week low/high is $1.00/$3.04999995.
Blue Eagle Lithium, Inc. (BEAG)
All Penny Stocks, Simply Wall St, Nasdaq, Financial Buzz, Stockhouse, OTC Markets, Last10k, and Market Screener reported earlier on Blue Eagle Lithium, Inc. (BEAG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A lithium exploration company, Blue Eagle Lithium, Inc. engages in identifying, evaluating, and developing early-stage lithium exploration opportunities in North America. The design of the Company’s growth strategy is to maximize shareholder value through a singular emphasis on lithium exploration and development in secure and stable North American regions. OTCQB-listed, Blue Eagle Lithium has its corporate headquarters in Henderson, Nevada.
The Company’s initial property is in Railroad Valley, Nevada, a highly prospective green-fields Petro-Lithium brine target region that features numerous similarities to the nearby Clayton Valley and which Blue Eagle Lithium believes warrants an extensive exploration program. It has a 100 percent Working Interest (WI) in 276 placer claims in Railroad Valley.
The Company’s Railroad Property warrants surface and shallow drilling evaluation for possible surface-mineable lithium-rich units based on different sources of geological data. The main exploration target within the Railroad Property would be more recent playa sediments, mostly within 2,000 feet (610 meters) of the valley’s surface. Railroad Valley is an isolated sedimentary basin. It exhibits all the important attributes of a large commercial petro-lithium discovery.
Recently, Blue Eagle Lithium announced that it has engaged Rangefront Geological to begin an extended soil sampling program covering its original 4,000 acre land position in Railroad Valley and its recently acquired acreage, the latter of which has received only limited evaluations to date. Rangefront Geological is a premier geological contracting and consulting company based locally out of Elko, Nevada. A crew from Rangefront will be mobilized to start work on the properties with the goal to gather up to 250 near surface clay and brine samples.
In addition, Blue Eagle Lithium announced it further extended its land package through the exercise of an option agreement clause. This extends its land holdings by an additional 520 acres (26 Mineral Claims). In total, the land package now held by Blue Eagle Lithium is 5,520 acres (276 claims, approximately 2,223 Hectares).
Blue Eagle Lithium, Inc. (BEAG), closed Wednesday's trading session at $0.08, up 33.3333%, on 148,876 volume with 22 trades. The average volume for the last 3 months is 39,429 and the stock's 52-week low/high is $0.009999999/$1.41999995.
Natural Health Farm Holdings, Inc. (NHEL)
Stockopedia, Stockhouse, Market Exclusive, Capital Cube, 4-Traders, Street Insider, Morningstar, Simply Wall St, InvestorsHub, OTC Markets, GuruFocus, MarketWatch, Last10k, and Barchart reported earlier on Natural Health Farm Holdings, Inc. (NHEL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Natural Health Farm Holdings, Inc. is a biotechnology company working to establish a complete healthcare one-stop shop based on natural or naturopathic products. Since November of 2017, the Company has developed and started to commercialize the web-based Naturopathic Learning Management System to enable consumers and distributors to be educated on health-related aspects of various diseases and nutritional consulting services. Natural Health Farm Holdings is headquartered in Las Vegas, Nevada. The Company lists on the OTCQB.
Natural Health Farm provides online nutritional consultation services. It does so through offering a web-based naturopathic learning management system. This system educates their customers on general wellbeing. The Company’s principal activities are in retailing nutritional supplements, organic foods and health-care related products.
Via its subsidiary, NHF International Limited, Natural Health Farm specializes in biotechnology research & development, and a retail business. It has a chain of numerous retail & franchise outlets throughout Malaysia and other nations. These include Singapore, Brunei, Philippines, China, Hong Kong and the United States.
Natural Health Farm Holdings announced this past January that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Tech R&D Sdn Bhd, a BioNexus accredited research and development company in Malaysia. With the agreement, Natural Health Farm shall acquire 100 percent of Natural Tech R&D’s outstanding shares for USD 1 Million.
Natural Health Farm Holdings also announced in January that it executed a term sheet to acquire all of the issued and outstanding shares of Excel Herbal Industries Sdn Bhd. Excel Herbal is a nutraceutical biotechnology manufacturing, organic food and health supplements business in Malaysia.
Recently, Natural Health Farm Holdings announced that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Health Naturopathic Academy Sdn Bhd (NHNA), a Malaysian healthcare education provider. Natural Health Naturopathic Academy offers courses on health, nutrition, dietetic and Chinese & natural medicine, which are accredited by over 30 countries.
Natural Health Farm Holdings also recently announced that it executed a term sheet to acquire a majority equity interest in Biodelta (Pty) Ltd. Biodelta is a contract developer and manufacturer of nutraceutical products in South Africa. Furthermore, this month, the Company announced that it executed an agreement to acquire all the issued and outstanding shares of Natural Health Farm, Inc. (NHF). NHF is a distributor of naturopathic and nutraceutical products in North Carolina and throughout the East Coast of the United States.
Natural Health Farm Holdings, Inc. (NHEL), closed Wednesday's trading session at $0.02, up 66.6667%, on 33,400 volume with 3 trades. The average volume for the last 3 months is 3,992 and the stock's 52-week low/high is $0.000099999/$6.00.
Pura Naturals, Inc. (PNAT)
Stockwatch, Clay Trader, Insider Financial, Marketwired, OTC Markets, WhaleWisdon, YCharts, Spotlight Growth, Tip Ranks, Dividend Investor, and MarketWatch reported on Pura Naturals, Inc. (PNAT), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Pura Naturals, Inc. is working to deliver a purer clean by way of its innovative BeBetter Foam®. The Company is the manufacturer of unique foam cleaning products for the home. It has its proprietary foam technology, which absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. Pura Naturals is based in Lake Forest, California.
The Company focuses on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, including facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.
Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). Pura Naturals’ household cleaning products deliver a unique soap infusion. The ground-breaking foam absorbs grease while repelling water and inhibiting bacteria growth and odors.
Pura Naturals also has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA). Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.
The Pura Marine division centers on developing solutions employing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors. Additionally, Pura Naturals has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner.
Pura also has its new line of health and beauty products. These products will be infused with Cannabidiol (CBD) derived from hemp and hemp seed oils.
Recently, Pura Naturals announced that the Grease Beast products went live on HomeDepot.com. Mr. Robert Doherty, Chief Executive officer of Pura Naturals, stated on December 12, 2018, "We have been live on HomeDepot.com for only a few days, and orders are flowing. This is a solid moment for Pura Naturals. Given the talent we have brought into the Company and the breadth of the achievements thus far, we expect a very strong 2019 for the Grease Beast product line."
Pura Naturals, Inc. (PNAT), closed Wednesday's trading session at $0.0003, up 50.00%, on 6,322,349 volume with 58 trades. The average volume for the last 3 months is 19,098,020 and the stock's 52-week low/high is $0.000199999/$0.010099999.
CareView Communications, Inc. (CRVW)
Tiny Gems, MissionIR, Stockopedia, Stock Invest, Monster Stocks Pick, FeedBlitz, Real Pennies, PennyTrader Publisher, Wall Street Resources, Wallet Investor, Plunkett Research, TradingView, BabyBulls, Pink Investing, Stock Stars, and Capital Cube reported previously on CareView Communications, Inc. (CRVW), and today we report on the Company, here at the QualityStocks Daily Newsletter.
CareView Communications, Inc. is an Information Technology (IT) provider to the healthcare industry. CareView provides the next generation of patient care through its cutting-edge data and patient monitoring system. This system connects patients, families and healthcare professionals (the CareView System®). The CareView System can help a hospital reduce sitter costs, patient falls and injuries, manage patient flow, improve internal communications, and consolidate vendors. OTCQB-listed, CareView Communications has its corporate headquarters in Lewisville, Texas.
The CareView System is HIPAA (Health Insurance Portability and Accountability Act) -compliant and secure. The System does not record anything. Additionally, it can include consent processes and privacy options. Pertaining to hospital benefits, the CareView System enables patients to watch first-run movies and access high-speed internet. The result of this is increased patient satisfaction.
CareView Communications’ proprietary, high-speed data network system may be installed throughout a healthcare facility to provide the facility with recurring revenue and infrastructure for future applications. The CareView System allows for close observation of high-risk patients from numerous locations. The CareView Connect® mobile application provides patient monitoring and critical communication tools from an existing Wi-Fi Android or iOS device. The CareView System employs an infrared camera in patient rooms to deliver real-time visual monitoring 24/7.
CareView Communications offers its CareView Connect Senior Care Quality of Life System™. This is a unique family of products and services, which improve the quality of life and safety of seniors who reside in independent and assisted living facilities, or who live alone at home. The CareView Connect Senior Care Quality of Life System™ consists of a small emergency assist button or pendant, passive motion sensors, bed sensors, and event sensors. The CareView Connect System passively monitors a resident's daily activities.
Recently, CareView Communications announced the execution of a three-year group purchasing agreement with Pandion Optimization Alliance. Pandion is a 70-year old not-for-profit group purchasing organization dedicated to member hospitals, non-acute health-care related facilities and related industries. Pandion GPO has thousands of members covering 50 states. Pandion GPO provides an assortment of supply chain services and solutions including group purchasing and supply chain consulting to help lessen costs, streamline operations and improve performance of its members.
CareView Communications, Inc. (CRVW), closed Wednesday's trading session at $0.016, up 77.7778%, on 20,810 volume with 4 trades. The average volume for the last 3 months is 142,393 and the stock's 52-week low/high is $0.004999999/$0.0285.
Lexington Biosciences, Inc. (LXGTF)
Awesome Penny Stocks, Penny Stock Hub, MarketWatch, Morningstar, Interactive Brokers, TradingView, Dividend Investor, Tech Stock Insider, InvestorsHub, Wallet Investor, 4-Traders, and Market News Updates reported earlier on Lexington Biosciences, Inc. (LXGTF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
A medical device company, Lexington Biosciences, Inc. is developing the HeartSentry. This is a new non-invasive diagnostic device to measure and monitor cardiovascular health through assessing the function of a person's vascular endothelium. This is the vital innermost lining of a person's cardiovascular system. The Company’s aim is to become a leader in the development of clinical grade cardiovascular self-measurement solutions for home and clinical use. Lexington Biosciences has offices in Vancouver, British Columbia; and Reno, Nevada.
Lexington is engaged with the US FDA (Food and Drug Administration) and other regulatory agencies on the required product approvals for the HeartSentry. HeartSentry targets the fast-growing self-measurement medical device sector. The design of the HeartSentry unit is to use Bluetooth and Cloud technology to provide up-to-date and accurate readings of an individual’s total cardiovascular health via electronic monitoring for risk-assessment and treatment effectiveness targeting the prevention of heart attack and stroke.
HeartSentry is its flagship, and first device currently advancing to commercial deployment. The HeartSentry core technology underwent development at the University of California Berkeley over a fifteen-year research and development (R&D) period involving many research studies and product iterations resulting in a portfolio of numerous pending and issued patents licensed to Lexington Biosciences.
Lexington Biosciences announced earlier this year the completion of the initial HeartSentry study conducted at San Francisco Bay-area Diablo Clinical Research. Lexington Biosciences’ goal is to make HeartSentry accurate, fast, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person's cardiovascular health.
Recently, Lexington Biosciences completed its first phase of clinical testing at Diablo Clinical Research. The results of the study validated safety protocols, provided Lexington with critical information for product iteration, algorithm development, and clinical testing protocol refinement in preparation for the forthcoming multi-center clinical study series.
Lexington Biosciences, Inc. (LXGTF), closed Wednesday's trading session at $0.065, up 62.50%, on 4,150 volume with 9 trades. The average volume for the last 3 months is 7,792 and the stock's 52-week low/high is $0.018699999/$1.29999995.
Ocean Thermal Energy Corporation (CPWR)
InvestorsHub, MarketWatch, YCharts, 4-Traders, Insider Monkey, Tidal Energy Today, Stockhouse, OTC Markets, Barchart, Investopedia, Marketbeat, and Simply Wall St reported earlier on Ocean Thermal Energy Corporation (CPWR), and today we choose to report the Company, here at the QualityStocks Daily Newsletter.
Ocean Thermal Energy Corporation constructs and operates clean hydrothermal energy plants around the word. The Company is a project developer for Ocean Thermal Energy Conversion (OTEC) plants that create renewable energy. It designs and develops deep-water hydrothermal clean-energy systems, which produce fossil-fuel free electricity through OTEC and environmentally friendly cooling through Seawater Air Conditioning (SWAC). OTCQB-listed, Ocean Thermal Energy is headquartered in Lancaster, Pennsylvania.
Seawater Air Conditioning (SWAC) technology generates air conditioning without the use of chemical agents. Acting alone, SWAC can reduce electricity usage by up to 90 percent in comparison to traditional air conditioning systems. When developed in association with OTEC plants, SWAC operates entirely without the use of fossil fuels.
OTEC leverages the temperature difference in the ocean between cold deep water and warm surface water in the tropics and subtropics to generate unlimited energy without the use of fossil fuels. In a closed cycle OTEC system, water flows through a large pipe and heat exchanger that heats a liquid with a low boiling point, such as ammonia. As the boiling ammonia produces steam, it turns a turbine generator to generate electricity.
A second pipe extracts cool deep water from the ocean that condenses the steam back to liquid form. As the ammonia is recycled, the process repeats, creating unlimited clean energy, 24 hours a day, 365 days a year (The Rankine Cycle). OTEC uses the solar energy from the ocean. No fossil fuels are used.
Ocean Thermal Energy has made significant progress on the development of its first OTEC EcoVillage. The Company has advanced toward the development of a SWAC system for the U.S. Military. The OTEC EcoVillage project comprises, in part, of an OTEC plant that will provide all power and water to approximately 400 residences. Additionally, it consists of a hotel, and shopping center, and models of sustainable agriculture, food production, and other economic developments.
Concerning the OTEC EcoVillage, the U.S. Virgin Islands’ Public Service Commission granted Ocean Thermal Energy regulatory approval for an OTEC plant. OTEC EcoVillage will be the first development in the world offering a net-zero carbon footprint.
Recently, Ocean Thermal Energy announced that it signed a Letter of Intent (LOI) to acquire an established, profitable, and experienced company in the heavy-commercial air conditioning business. The acquired company would bring considerable heavy-commercial air conditioning expertise and strong operational synergies. Furthermore, in August, Ocean Thermal Energy announced the appointment of three new members to its advisory board. These are Eric Moser, Founder and President of Moser Design Group; Julia Sanford, Founding Principal of Starr Stanford Design Associates; and Steve Mouzon, Principal at Mouzon Design.
Ocean Thermal Energy Corporation (CPWR), closed Wednesday's trading session at $0.0489, up 63.00%, on 13,000 volume with 4 trades. The average volume for the last 3 months is 16,529 and the stock's 52-week low/high is $0.024599999/$0.129999995.
American Power Group Corp. (APGI)
Marketbeat.com, Stock News Now, and SmallCapVoice reported on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.
The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time. It is a ground-breaking non-invasive energy enhancement system.
American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.
Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.
The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.
Recently, American Power Group announced that it will extend the filing of its June 30, 2017 Quarterly Form 10Q through SEC Form 12b-25. The Company announced on June 6, 2017, a corporate wide realignment of its strategic direction, reallocation of resources, and reduction in workforce in response to considerable operating losses because of the effect that ongoing low oil prices were having on its dual fuel and flare capture businesses. The realignment resulted in a decrease in annual operating costs of greater than $2 million on a going forward basis.
American Power Group Corp. (APGI), closed Wednesday's trading session at $0.0095, up 58.3333%, on 9,560 volume with 4 trades. The average volume for the last 3 months is 15,298 and the stock's 52-week low/high is $0.002899999/$0.137500002.
The QualityStocks Company Corner
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- Sigma Labs Inc. (NASDAQ: SGLB)
- Predictive Oncology (NASDAQ: POAI)
- ChineseInvestors.com (CIIX)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- HTC Extraction Systems (TSX.V: HTC)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- No Borders Inc. (OTC: NBDR)
- InsuraGuest Inc.
- Endonovo Therapeutics Inc. (ENDV)
- SinglePoint, Inc. (SING)
- Spectrum Global Solutions, Inc. (SGSI)
- MCTC Holdings Inc. (OTC: MCTC)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted today in a publication from Motley Fool, examining how OGI won't announce its Q4 results until next week. But the cannabis producer provided an update last week with preliminary results that were well below expectations. And the company attributed the disappointing numbers to [drum roll, please]. Ontario. CEO Greg Engel said, "The lack of a sufficient retail network and slower than expected store openings in Ontario continued to impact sales in Q4 2019 and were further exacerbated by increased industry supply." Also today, OGI was featured today in a report by PennyStocks.com looking at attractive penny stocks in the space. The first cannabis penny stock to watch is Organigram Holdings (OGI Stock Report). Like many other cannabis companies in the industry, OrganiGram had also suffered from a bit of a slump in recent weeks. On Tuesday, the stock jumped significantly. OGI stock soared by as much as 11.7% at one point and experts believe that is due to the recent industry events.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Wednesday's trading session at $2.46, up 6.0345%, on 6,209,404 volume with 17,001 trades. The average volume for the last 3 months is 1,813,375 and the stock's 52-week low/high is $2.00/$8.43999958.
- Blame It on Ontario: Why 1 Province Is the Main Culprit Behind the Canadian Cannabis Industry's Woes
- 5 Penny Stocks To Watch After Latest Marijuana Industry Move
- Industry Upset as Germany Classifies CBD as a Novel Food
Sigma Labs Inc. (NASDAQ: SGLB)
Sigma Labs, Inc. (NASDAQ:SGLB) ("Sigma Labs"), a leading developer of quality assurance software for the commercial 3D printing industry, has been awarded a contract by the Fraunhofer Research Institution for Additive Manufacturing Technologies (IAPT), an additive manufacturing research innovator and early adopter of PrintRite3D®, to upgrade its current version PrintRite3D system to version 5.1. Also today, the company was highlighted in a publication from GlobeNewswire, examining how the company announced its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities. To view the full publication, titled “Profiting from the Fourth Industrial Revolution,” visit: http://nnw.fm/1WhBz
Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.
For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.
Revolutionizing Additive Manufacturing
Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.
Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.
Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.
Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.
Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.
Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.
Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.
Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.
Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.
John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.
Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.
CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.
Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.
Sigma Labs Inc. (SGLB), closed Wednesday's trading session at $1.02, up 13.3333%, on 351,686 volume with 842 trades. The average volume for the last 3 months is 164,049 and the stock's 52-week low/high is $0.451099991/$2.46000003.
- Sigma Labs Awarded PrintRite3D Upgrade Contract with Leading Industry Research Institute Fraunhofer IAPT
- Sigma Labs Featured in Publication Discussing Advanced 3D Printing Capabilities in Global Manufacturing
- Profiting from the Fourth Industrial Revolution
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology (NASDAQ: POAI), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its entry into a $15 million common stock purchase and registration rights agreement with Oasis Capital, LLC, a Puerto Rico limited liability company. To view the full press release, visit http://nnw.fm/Y94gA
Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.
Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:
- A database of clinically validated historical and outcome data from patient tumors
- An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
- A “smart” patient-derived tumor profiling platform
- An in-house bioinformatics artificial intelligence (AI) platform
- A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
- An FDA-approved fluid collection and disposal system
Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.
Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.
Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.
Predictive Oncology (POAI), closed Wednesday's trading session at $3.80, up 2.7027%, on 29,284 volume with 100 trades. The average volume for the last 3 months is 24,628 and the stock's 52-week low/high is $3.31999993/$8.50.
- Predictive Oncology Inc. (NASDAQ: POAI) Secures $15 Million Equity Line
- Predictive Oncology Inc. (NASDAQ: POAI) CEO Discusses Corporate, Scientific Milestones in NetworkNewsAudio Interview
- Predictive Oncology Inc.’s (NASDAQ: POAI) TumorGenesis Technology May Prove Critical in New Cancer Drug Development
ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced that a recent interview with its CEO Warren Wang on The RedChip Money Report television program aired on Bloomberg International on November 17, with the broadcast available in 149 million homes across Europe, the Middle East and Africa. To view the full press release, visit http://cnw.fm/2Weh8.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Wednesday's trading session at $0.2675, up 2.0992%, on 81,388 volume with 31 trades. The average volume for the last 3 months is 44,413 and the stock's 52-week low/high is $0.165000006/$0.654999971.
- ChineseInvestors.com Inc. (CIIX) CEO Eyes Opportunity for CBD Divisions in Interview on RedChip Money Report
- Industry Upset as Germany Classifies CBD as a Novel Food
- ChineseInvestors.com Inc. (CIIX) CEO Featured in RedChip Money Report Interview, Describes Tremendous Opportunity in China’s CBD Cosmetics Market
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in the 420 with CNW by CannabisNewsWire. The booming marijuana sector and the ever-growing hemp-derived CBD industry has attracted the attention of celebrities and athletes who are signing up to pitch for either of the brands. On Thursday, the hip-hop artist Drake whose full name is Aubrey Drake Graham, entered into a partnership with Canopy Growth, a Canadian pot company, to launch his own cannabis company, More Life Growth in his hometown, Toronto.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Wednesday's trading session at $0.8539, up 1.6548%, on 387,661 volume with 362 trades. The average volume for the last 3 months is 230,631 and the stock's 52-week low/high is $0.739199995/$5.20499992.
- 420 with CNW – Superstar Drake Joins Cannabis Industry by Partnering with Canadian Pot Company
- 420 with CNW – Yale Teams Up With Weed Company to Study Effects of Cannabis on Stress
- Green Growth Brands to Hold First Quarter Fiscal 2020 Earnings Conference Call on November 26, 2019
HTC Extraction Systems (TSX.V: HTC)
HTC Extraction Systems (TSX.V: HTC) was featured today in a publication from HempWireNews, examining how one of the biggest challenges that hemp farmers have faced this season is the intensive labor demands of harvesting their crops. Industrial hemp has only been legalized recently, so the existing machinery is ill-suited to harvest these plants. However, a pair of farmers in Colorado appear to have developed a solution to this problem.
HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (TSX.V: HTC), closed Wednesday's trading session at $0.26, up 1.9608%, on 329,000 volume with 26 trades. The average volume for the last 3 months is 121,276 and the stock's 52-week low/high is $0.079999998/$1.24.
- Colorado Farmers Invent Novel Hemp Harvester
- New Jersey Senate Passes Bill Urging Feds to Enact CBD Dosage Guidelines
- 420 with CNW – Georgia’s Medical Marijuana Program Kicks into High Gear
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Plus Products, (CSE: PLUS) (OTCQX: PLPRF) strategy and healthy position in a depressed cannabis market. Also today, the company was highlighted in a publication from CBDWire, examining how PLPRF recently announced the appointment of ecommerce senior executive Jill Braff to the company’s board of directors (http://cnw.fm/Hr3iT ). The move is aimed at further strengthening the company’s already impressive digital sales and marketing expertise.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Wednesday's trading session at $1.4926, up 6.25%, on 45,023 volume with 72 trades. The average volume for the last 3 months is 39,971 and the stock's 52-week low/high is $1.08749997/$6.00810003.
- Bankrolled and Executing, Plus Products Looks to Finish 2019 Strong -- CFN Media
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Appointment of Ecommerce Exec to Board of Directors
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Focused on Owning Branded-CBD Space
Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood Holdings (OTCQB: NGTF), the innovative company addressing America’s $50 billion annual night snacking spend, today announced its receipt of confirmation that sleep-friendly Nightfood ice cream will soon be made available in a large division of one of the nation’s top-10 supermarket chains. To view the full press release, visit http://nnw.fm/h5gXY.
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Wednesday's trading session at $0.25, even for the day, on 133,588 volume with 45 trades. The average volume for the last 3 months is 142,792 and the stock's 52-week low/high is $0.165999993/$0.920000016.
- Nightfood Holdings Inc. (NGTF) Secures Distribution Commitment from Additional Top-10 Supermarket Chain
- Nightfood Holdings Inc. (NGTF) Presenting at Today’s “Next Super Stock Live!” Online Investor Conference Hosted by Wall Street Reporter
- Wall Street Reporter presents: “NEXT SUPER STOCK Live!” Investor Conference November 14, 2019
No Borders Inc. (OTC: NBDR)
No Borders Inc. (OTC: NBDR) was featured today in a publication from HempWireNews, examining how hemp is undoubtedly one of the most versatile cash crops being grown at the moment. It has plenty of applications ranging from fiber clothing, industrial foodstuffs, beauty, and health. Over the past few years, it has become an increasingly attractive venture, mainly carried by the immense popularity for hemp-derived cannabidiol (CBD) that’s currently taking the world by storm.
No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.
Different by Design
Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.
The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.
With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.
- No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
- No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
- No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
- No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
- No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.
No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.
COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.
CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.
Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.
No Borders Inc. (NBDR), closed Wednesday's trading session at $0.016, even for the day, on 40,807 volume. The average volume for the last 3 months is 77,781 and the stock's 52-week low/high is $0.007699999/$0.048799999.
- Is Smokable Hemp the Next Big Thing in Kentucky?
- Coverage Initiated for No Borders Inc. via NetworkNewsWire
- No Borders Inc. (NBDR) is “One to Watch”
The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Inc..
Service-as-a-software (SaaS) company InsuraGuest Inc.has entered the rapidly growing vacation rental market with its proprietary software platform offering specialized insurance coverage to all guests from check-in to check-out. InsuraGuest’s innovative InsurTech platform protects guests during their stay at vacation rental properties in an industry that is expected to host more than 297 million total vacation rental users worldwide in 2019 (http://nnw.fm/2efgJ).
InsuraGuest Inc. is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship InsurTech software platform to provide specialized insurance products to end users in the business-to-business (B2B) and business-to-consumer (B2C) markets. The company’s first focus is on the B2B hotels and vacation rentals sectors, where its API integrates with the clients’ property management systems to offer guests a specialized guest protection policy. The platform and policy combination “InsurTech” product helps transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.
InsuraGuest’s platform is currently capable of integrating with approximately 70 different hotel and vacation rental property management systems, giving it access to roughly 40,000 properties worldwide.
The company continues to pursue expansion opportunities and recently signed a Letter of Intent with a master general agent in the United Kingdom and Europe to distribute its platform and products to hotel and vacation rental markets in those regions, as well as plans to expand to Asia in 2020.
Protecting Guests, Enhancing Customer Experience
InsuraGuest is the first line of defense for both the property and the guest.
InsuraGuest is purchased by the hotel or vacation rental “property,” which offers the policy to each registered guest and its occupants for an additional fee. The specialized policy affords coverage for theft of personal property while in the hotel, as well as accidental medical expense and accidental death and dismemberment, up to the policy limits of $2,500 to $50,000.
The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United State alone, where there are approximately 4.5 million second homes are being managed by a third-party rental company.
With distribution in Europe and the United States, InsuraGuest’s demographics combined will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.
Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit.
Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Specialized Guest Protection Policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.
- Targeting hotels and vacation rentals, a multi-billion-dollar industry
- Providing the first line of defense in case of accident, loss or death
- Expanding distribution reach with footing in European hotel and vacation rental markets
- Expansion into Asia by 2020
Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.
Anderson earned a BS undergraduate degree in Consumer Studies with an emphasis in Architecture as an undergraduate at the University of Utah. He subsequently earned his Master’s in Business Administration. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.
Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends.
Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.
Christopher J. Panos Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.
Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018. He also has served as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.
Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.
- InsuraGuest Gains Firm Foothold on $57.669 Billion Vacation Rental Market with its State-of-the-Art InsurTech Guest Protection Platform
- InsuraGuest Inc. Provides First Line of Defense for Vacation Rental Industry and Guests
- InsuraGuest Inc. Enables Hotels, Vacation Rental Properties to Offer Guests’ Insurance Protection
Endonovo Therapeutics Inc. (ENDV)
Commercial-stage developer of innovative medical devices Endonovo Therapeutics Inc.’s (OTCQB: ENDV) proprietary SofPulse(R) technology is being successfully used by surgeons at New Hanover Regional Medical Center (NHRMC) in North Carolina to reduce the volume of opioid prescriptions and remove the need for patients to take narcotics for pain after surgery.
Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.
In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.
SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s targeted pulsed electromagnetic field (tPEMF) transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.
Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.
Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.
Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.
Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.
Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.
Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.
Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.
David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.
Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.
Steven C. Levin, M.D., Scientific Advisory Board Member
Dr. Steven C. Levin is the regional medical director at Johns Hopkins School of Medicine and medical director at Howard County General Hospital in Columbia, Maryland. Additionally, he is an assistant professor at Johns Hopkins School of Medicine, Department of Anesthesiology. Dr. Levin is currently the co-chair of the Opioid Stewardship Clinical Community as well as a clinical design team leader of the Musculoskeletal Center in the Johns Hopkins Health System. Additionally, Dr. Levin has previously served on the medical school facility at Yale University and at University of Pittsburgh Medical Center. Dr. Levin received his undergraduate degree from University of Pennsylvania and medical degree at the University of Pittsburgh. He completed his residency and fellowship at the University of Pittsburgh Medical Center. His membership in professional and scientific societies has included the American Society of Anesthesiology, American Pain Society, American Society of Regional Anesthesia, Society in Anesthesia and International Association for the Study of Pain.
Peter Novak, M.D., Ph.D., Scientific Advisory Board Member
Dr. Peter Novak is the director of the Autonomic Laboratory at the Department of Neurology, Brigham and Women’s Hospital in Boston, Massachusetts. He is a board-certified neurologist and a board-certified autonomic specialist. He is a member of the American Academy of Neurology, American Autonomic Society and the Autonomic Board of United Council for Neurologic Subspecialties. Dr. Novak graduated from medical school in Bratislava, Slovakia, and completed his neurology residency at Ohio State University. He also completed postdoctoral studies focusing on cardiovascular and autonomic research at Charles University (Prague) the University of Montreal, McGill University (Montreal) and the Mayo Clinic. He has special interests in autoimmune, small fiber and autonomic neuropathies, autoimmune, postural orthostatic tachycardia syndrome and multiple system atrophy. He has written over 70 papers and presented at numerous conferences.
Geoffrey Abrams, M.D., Scientific Advisory Board Member
Dr. Geoffrey Abrams is an assistant professor of orthopedic surgery at the Stanford University School of Medicine and the director of sports medicine for Stanford’s varsity athletes. He specializes in orthopedic sports medicine and arthroscopy of the shoulder, knee and elbow as well as upper extremity joint replacement surgery. Dr. Abrams is a member of the American Academy of Orthopedic Surgeons (AAOS) and the American Orthopedic Society for Sports Medicine (AOSSM), among others, and currently serves as assistant team physician for the NFL’s San Francisco 49ers as well as head team physician for a number of Stanford University varsity athletic teams. He is actively involved in research focusing on the role of inflammatory mediators, and microRNA in particular, on cartilage and tendon damage. Dr. Abrams received his undergraduate degree from Stanford University and his doctorate of medicine from the University of California – San Diego. He completed his residency in orthopedic surgery at Stanford University and went on to receive additional training in Orthopedic Sports Medicine and Shoulder Surgery at Rush University Medical Center in Chicago, Illinois. Dr. Abrams has authored or co-authored over 60 peer-reviewed scientific articles, over 20 book chapters, has presented original research at numerous national and international scientific meetings, and serves as a reviewer for numerous sports medicine scientific journals.
Dr. William Li, Scientific Advisory Board Member
Dr. William Li is CEO and co-founder of the Angiogenesis Foundation. He trained in the lab of Dr. Judah Folkman, pioneer of the angiogenesis field, and has been actively engaged in angiogenesis research and clinical development for 30 years. Under Dr. Li’s leadership, the foundation has developed a unique social enterprise model based on value-creating collaborations with leading biopharmaceutical and medical device companies. Dr. Li is actively engaged in identifying unmet needs in the healthcare space for which clinical and cost-effective technology can offer beneficial solutions. He is a graduate of Harvard, and completed his medical residency training at Massachusetts General Hospital in Boston. He serves as advisor and consultant to leading global public and private companies.
Mykol Larvie, Scientific Advisory Board Member
Recipient of three Harvard Medical Student Teaching awards in Principal Clinic Experience, Mykol Larvie is currently a radiologist in the Cleveland Clinic’s Divisions of Nuclear Medicine and Neuroradiology as well as the director of Functional and Molecular Neuroimaging. With a completed internship in the Department of Medicine as well residency in the Department of Radiology and fellowship in the Division of Neuroradiology at the Massachusetts General Hospital, Dr. Larvie specializes in PET examinations of the brain performed typically for the evaluation of neurodegenerative disease, seizure and tumor. He delivers didactic lectures and case conferences to residents and fellows six times per year and serves as a mentor and advisor to medical students, residents and fellows.
Nathan L. Guerette, Scientific Advisory Board Member
Nathan L. Guerette is the director and president of the Female Pelvic Medicine Institute of Virginia; an associate clinical professor in the division of Urogynecology and Pelvic Reconstructive Surgery at the Medical College of Virginia; a full clinical professor in Urogynecology and Pelvic Reconstructive Surgery at the Riverside Regional Medical Center; and the Robotic Surgery director at the Chippenham and Johnston Willis Medical Center. With a completed fellowship in urogynecology and pelvic reconstructive surgery at the Cleveland Clinic Foundation, Dr. Guerette has won seven awards in the medical and humanitarian departments. He has made nine media appearances, some of which were on PBS and NBC News. He has three board certiﬁcations and has ran a surgical mission trip to Trujillo, Peru, through Bon Secours.
Dr. Ashling O’Connor, Scientific Advisory Board Member
Currently a surgeon at the Comprehensive Breast Health Center of the Lahey Medical Center, Dr. O’Connor has won seven awards in the surgical department. She has completed a surgical internship at the Mater Misericordiae Hospital in Dublin as well as a breast surgery fellowship at the University of Massachusetts Interdisciplinary Breast Fellowship. She mentors medical students and surgical residents both in the operating room and in a clinical setting and enjoys biking and triathlons as well as trail and marathon running. She is certiﬁed in the Hidden Scar technique in breast surgery as well as in the advanced cardiac life support and is a member of the Protocol Review Committee Umass Memorial Medical Center, the New England Surgical Society and the American College of Surgeons.
Samir Awad, Scientific Advisory Board Member
Samir Awad has worked for the Department of Veterans Affairs since 2000. He has served as the operative care line associate executive, chief of general surgery, and medical director of the Surgical Intensive Care Unit at the MEDVAMC. Dr. Awad’s areas of specialty include liver, pancreas, and acute care surgery, as well as minimally invasive surgical procedures. He is a member of the Association for Academic Surgeons, the Society of University Surgeons, the American College of Surgeons, the Surgical Infection Society, and the Society for Critical Care Medicine. Dr. Awad has authored more than 100 peer-reviewed and invited publications and is the recipient of numerous awards for surgical and research achievements. Dr. Awad is certified by the American Board of Surgery and Surgical Critical Care.
Endonovo Therapeutics Inc. (ENDV), closed Wednesday's trading session at $0.0033, off by 28.2609%, on 22,001,211 volume with 163 trades. The average volume for the last 3 months is 4,897,120 and the stock's 52-week low/high is $0.0031/$0.040899999.
- Endonovo Therapeutics Inc.’s (ENDV) Electroceutical Device Brings Rapid Pain Relief, Leads to 30-40% Decrease in Post-Surgical Narcotic Prescriptions
- Endonovo Therapeutics Reports Third Quarter 2019 Results
- Endonovo Therapeutics Inc. (ENDV) Offers Bright Spot in Opioid -Addiction Space with New Pain-Management Option
SinglePoint, Inc. (SING)
Direct Solar, a subsidiary of SinglePoint (OTCQB: SING), on Tuesday reported that it continues to exceed revenue growth targets and has been key to improving the company’s financials. Among other highlights, Direct Solar originated contracts totaling $4,965,975 and opened in three new states during the third quarter of 2019. To view the full press release, visit http://nnw.fm/o13kN.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Wednesday's trading session at $0.0103, off by 3.1955%, on 4,409,811 volume with 98 trades. The average volume for the last 3 months is 2,709,840 and the stock's 52-week low/high is $0.009999999/$0.028799999.
- SinglePoint, Inc. (SING) Subsidiary Exceeds Revenue Growth Goals in Q3 2019
- Solar Stock News: SinglePoint Subsidiary Direct Solar Making Major Headway as Expansion Continues
- 420 with CNW – Pew Poll Finds Increased Support for Marijuana Legalization
Spectrum Global Solutions, Inc. (SGSI)
Spectrum Global Solutions, Inc. (OTCQB: SGSI), a leading single-source provider of next-generation communications network, technology, infrastructure and maintenance solutions, reported financial results for the third quarter ended September 30, 2019.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Wednesday's trading session at $0.03783, off by 0.447368%, on 80,650 volume with 15 trades. The average volume for the last 3 months is 186,740 and the stock's 52-week low/high is $0.014999999/$0.419999986.
- Spectrum Global Solutions Reports Third Quarter 2019 Financial Results
- Spectrum Global Solutions Inc. (SGSI) Adds $2.5 Million in New Contracts to $137 Million Opportunity Pipeline
- Spectrum Global Solutions Announces Closing of WaveTech GmbH Acquisition
MCTC Holdings Inc. (OTC: MCTC)
MCTC Holdings, Inc. (MCTC), today announces an expanded R&D program designed to produce polymeric nanoparticles of cannabinol (CBN). Expansion of the Company's R&D program also includes a goal of creating nanoparticles of cannabinoid glycosides. MCTC believes such nanoparticles and nanofibers will hold significant future commercial viability. Also today, the company was featured in a publication from CBDWire, examining the expanded R&D program in greater detail. To view the full press release, visit http://cnw.fm/NhHr4
MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.
With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).
MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.
The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):
- Significantly improving bioavailability
- Allowing for ultra-high loading rates
- Enhancing customization of cannabinoid combinations
- Improved dosing precision
- Providing more control in release parameters
MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.
MCTC has now filed four patents on its cannabinoid delivery technology systems:
- The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
- Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
- Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
- Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.
MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).
MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.
MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.
MCTC Holdings Inc. (MCTC), closed Wednesday's trading session at $0.6862, off by 14.225%, on 36,857 volume with 24 trades. The average volume for the last 3 months is 9,744 and the stock's 52-week low/high is $0.075000002/$3.00.
- MCTC Expands Research and Development Program to Include Polymeric Nanoparticles of Cannabinoid Glycosides and Cannabinol (CBN)
- MCTC Holdings Inc. (MCTC) Expands Research and Development Program
- Why MCTC Holdings Inc. (MCTC) Is ‘One to Watch’
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Secures Fully Reporting Status with SEC
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Entry into Second Phase Development of Immersive Educational Materials
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Comments on Recent Unauthorized Promotional Activity in Response to OTC Markets Request
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Reports Q2 Fiscal Year 2020 Financial Results, Provides Corporate Update
- ChineseInvestors.com (CIIX) CEO Featured in RedChip Money Report Interview, Describes Tremendous Opportunity in China’s CBD Cosmetics Market
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Puts Cultivation on Hold to Focus on Extraction, Edibles and Distribution
- CloudCommerce (OTCQB: CLWD) Benefiting from Dramatic Transition to Digital Advertising
- Dama Financial - Enters Strategic Partnership with PayWana
- Endonovo Therapeutics (OTCQB: ENDV) SofPulse(R) Reduces Opioid Prescriptions at New Hanover Regional Medical Center
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Third Quarter 2019 Financial Results
- Genprex, Inc. (NASDAQ: GNPX) Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month
- GP Solutions (GWPD) Announces Launch of “Prolific Soilless Growth Medium” and “Prolific Hydro” on Amazon
- Grapefruit Boulevard Investments Inc. (IGNG) Can CBD Help Cure Hangovers?
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Survey Shows Americans Think the FDA Regulates the CBD Industry
- Green Hygienics Holdings Inc. (OTC: GRYN) 420 with CNW – What You Need to Know to Grow Marijuana in a Greenhouse
- Hemptown USA - Premier CBG Grower Worldwide, Expects Significant Revenue Boost in 2020
- HTC Extraction Systems (TSX.V: HTC) 420 with CNW – Georgia’s Medical Marijuana Program Kicks into High Gear
- InsuraGuest Inc. - Provides First Line of Defense for Vacation Rental Industry and Guests
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Cannabidiol Can Help to Manage Endometriosis Pain, New Study
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Cannabidiol Can Help to Manage Endometriosis Pain, New Study
- LiveWire Ergogenics Inc. (OTC: LVVV) Announces Financial Report for Q3 2019
- Marijuana Company of America Inc. (MCOA) 420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected
- MCTC Holdings Inc. (MCTC) USDA Hemp Testing Rules Invalidate Washington’s Preferred Protocol
- MustGrow Biologics Corp (CSE: MGRO) Intends to Tackle New Fusarium Pathogen Threatening Worldwide Banana Supply
- Neutra Corp. (OTCQB: NTRR) How the National Hemp Rules Could Affect Idaho
- Nightfood, Inc. (OTCQB: NGTF) Presenting at Today’s “Next Super Stock Live!” Online Investor Conference Hosted by Wall Street Reporter
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Cannabis Weekly Round-Up: Quarterly Updates Rock Market
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- OriginClear (OCLND) Sees Major Opportunity as the Permian Basin Experiences Water Shortage
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Successful Completion of Phase 1 Nickel/Cobalt Process Recovery Program
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Anticipated Automation Completion Date
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Appoints First-Ever Chief Scientific Officer
- Predictive Oncology Inc. (NASDAQ: POAI) Reports Q3 Results, 58% Revenue Increase
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
- Quest Patent Research Corp. (QPRC) Maintains Robust Portfolio of Diverse IP Assets
- Sharing Services Global Corporation (SHRG) Leading the Way Forward in World of Changing Needs for Consumers, Workers
- Sigma Labs, Inc. (NASDAQ: SGLB) Transforming the Creation of Critical 3D Metal Printing Components
- SinglePoint, Inc. (SING) Surging in $52.5 Billion Global Solar Market, Sees Solar Division Hitting $5 Million in Contracts by End of 2019
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $950K Purchase Order from Top US Distributor
- Spectrum Global Solutions, Inc. (SGSI) Announces Closing of WaveTech GmbH Acquisition
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected
- SRAX Inc. (NASDAQ: SRAX) Reports Q3 2019 Vertical Sales Increase 17% Year-over-Year and Net Income of $1.4 Million
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate in Two Upcoming Industry Conferences
- Sugarmade, Inc. (SGMD) Announces Ambitious Strategy as it Advances Plans to Uplist to Major US Exchange
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Blissco Launches New, Full-Spectrum CBD Oil, Pur Dew
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) USDA Hemp Testing Rules Invalidate Washington’s Preferred Protocol
- Trxade Group Inc. (TRXD) Bonum Health Unveils Next-Gen Healthcare Solution Coming Soon to Independent Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – What Women Should Know About Marijuana and Breast Cancer
- VPR Brands, LP (VPRB) How the National Hemp Rules Could Affect Idaho
- Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate in Cowen 2nd Annual Boston Cannabis Conference
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) Production Star Rising with Low-Risk Budget Model, Boom in Streaming Services
- Xalles Holdings Inc. (XALL) Offering Solutions in E-Commerce, Payments, Financial Reconciliation Sectors
- Youngevity International, Inc. (NASDAQ: YGYI) to Host November 18th Conference Call to Review Financial Statements, Provide Corporate Update
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.